"Anticonvulsants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs used to prevent SEIZURES or reduce their severity.
Descriptor ID |
D000927
|
MeSH Number(s) |
D27.505.954.427.080
|
Concept/Terms |
Anticonvulsants- Anticonvulsants
- Anticonvulsive Agents
- Agents, Anticonvulsive
- Anticonvulsive Drugs
- Drugs, Anticonvulsive
- Anticonvulsant Drugs
- Drugs, Anticonvulsant
Antiepileptic Agents- Antiepileptic Agents
- Agents, Antiepileptic
- Antiepileptics
- Antiepileptic Drugs
- Drugs, Antiepileptic
|
Below are MeSH descriptors whose meaning is more general than "Anticonvulsants".
Below are MeSH descriptors whose meaning is more specific than "Anticonvulsants".
This graph shows the total number of publications written about "Anticonvulsants" by people in this website by year, and whether "Anticonvulsants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 2 | 3 | 5 |
1998 | 3 | 0 | 3 |
1999 | 4 | 1 | 5 |
2000 | 1 | 2 | 3 |
2001 | 3 | 1 | 4 |
2002 | 6 | 1 | 7 |
2003 | 4 | 3 | 7 |
2004 | 3 | 5 | 8 |
2005 | 2 | 3 | 5 |
2006 | 3 | 1 | 4 |
2007 | 2 | 4 | 6 |
2008 | 8 | 2 | 10 |
2009 | 4 | 2 | 6 |
2010 | 2 | 2 | 4 |
2011 | 5 | 2 | 7 |
2012 | 3 | 0 | 3 |
2013 | 8 | 1 | 9 |
2014 | 2 | 0 | 2 |
2015 | 3 | 3 | 6 |
2016 | 3 | 2 | 5 |
2017 | 0 | 1 | 1 |
2018 | 2 | 3 | 5 |
2019 | 3 | 1 | 4 |
2020 | 3 | 2 | 5 |
2021 | 7 | 3 | 10 |
2022 | 0 | 2 | 2 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Anticonvulsants" by people in Profiles.
-
Optimizing Status Epilepticus Management in the Emergency Department: It's About Time. Adv Emerg Nurs J. 2023 Jan-Mar 01; 45(1):11-22.
-
Causes of New-Onset Seizures and Their Treatment in Children With Non-CNS Malignancies: A Retrospective Study in a Tertiary Care Center. Pediatr Neurol. 2022 12; 137:17-21.
-
Association of Time to Clinical Remission With Sustained Resolution in Children With New-Onset Infantile Spasms. Neurology. 2022 11 29; 99(22):e2494-e2503.
-
Long-term individual retention with cenobamate in adults with focal seizures: Pooled data from the clinical development program. Epilepsia. 2022 01; 63(1):139-149.
-
Safety and Efficacy of Natalizumab as Adjunctive Therapy for People With Drug-Resistant Epilepsy: A Phase 2 Study. Neurology. 2021 11 02; 97(18):e1757-e1767.
-
Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 10; 62(10):2505-2517.
-
Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 09; 62(9):2228-2239.
-
Efficacy of Home Anticonvulsant Administration for Second-Line Status Epilepticus Treatment. Neurology. 2021 08 17; 97(7):e720-e727.
-
The Effect of Sample Handling on Free Valproic Acid Levels. J Appl Lab Med. 2021 04 29; 6(3):645-653.
-
A phase 1b/2a study of soticlestat as adjunctive therapy in participants with developmental and/or epileptic encephalopathies. Epilepsy Res. 2021 08; 174:106646.